Cerity Partners’s CVS Health CVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $31.7M | Sell |
440,706
-6,181
| -1% | -$476K | 0.04% | 331 |
|
|
2025
Q4 | $35.5M | Sell |
446,887
-89,609
| -17% | -$7.06M | 0.05% | 289 |
|
|
2025
Q3 | $40.4M | Buy |
536,496
+104,401
| +24% | +$7.15M | 0.07% | 241 |
|
|
2025
Q2 | $29.8M | Sell |
432,095
-216,171
| -33% | -$14.2M | 0.05% | 283 |
|
|
2025
Q1 | $43.9M | Buy |
648,266
+129,535
| +25% | +$7.75M | 0.09% | 202 |
|
|
2024
Q4 | $24M | Sell |
518,731
-99,249
| -16% | -$5.57M | 0.05% | 281 |
|
|
2024
Q3 | $38.9M | Sell |
617,980
-107,360
| -15% | -$6.26M | 0.09% | 206 |
|
|
2024
Q2 | $42.8M | Sell |
725,340
-348,061
| -32% | -$21.8M | 0.11% | 166 |
|
|
2024
Q1 | $85.6M | Buy |
1,073,401
+123,706
| +13% | +$9.45M | 0.23% | 97 |
|
|
2023
Q4 | $75M | Buy |
949,695
+181,516
| +24% | +$12.9M | 0.25% | 96 |
|
|
2023
Q3 | $53.6M | Sell |
768,179
-361,282
| -32% | -$25.6M | 0.26% | 101 |
|
|
2023
Q2 | $78.1M | Buy |
1,129,461
+215,657
| +24% | +$15.3M | 0.3% | 76 |
|
|
2023
Q1 | $95.1M | Sell |
913,804
-157,035
| -15% | -$13.2M | 0.22% | 63 |
|
|
2022
Q4 | $99.8M | Buy |
1,070,839
+267,762
| +33% | +$25.8M | 0.64% | 30 |
|
|
2022
Q3 | $76.6M | Buy |
803,077
+35,153
| +5% | +$3.48M | 0.92% | 16 |
|
|
2022
Q2 | $71.2M | Buy |
767,924
+352,883
| +85% | +$34.4M | 0.79% | 16 |
|
|
2022
Q1 | $42M | Sell |
415,041
-347,180
| -46% | -$36.5M | 0.65% | 30 |
|
|
2021
Q4 | $78.6M | Buy |
762,221
+593,347
| +351% | +$54.8M | 1.2% | 11 |
|
|
2021
Q3 | $14.3M | Buy |
168,874
+22,310
| +15% | +$1.87M | 0.32% | 67 |
|
|
2021
Q2 | $12.2M | Buy |
146,564
+1,854
| +1% | +$152K | 0.27% | 77 |
|
|
2021
Q1 | $10.9M | Sell |
144,710
-12,591
| -8% | -$917K | 0.26% | 84 |
|
|
2020
Q4 | $10.7M | Buy |
157,301
+27,403
| +21% | +$1.78M | 0.34% | 61 |
|
|
2020
Q3 | $7.58M | Buy |
129,898
+46,368
| +56% | +$2.89M | 0.31% | 67 |
|
|
2020
Q2 | $5.42M | Buy |
83,530
+460
| +0.6% | +$29K | 0.3% | 67 |
|
|
2020
Q1 | $4.93M | Buy |
83,070
+6,967
| +9% | +$465K | 0.31% | 65 |
|
|
2019
Q4 | $5.65M | Sell |
76,103
-25,582
| -25% | -$1.8M | 0.29% | 73 |
|
|
2019
Q3 | $6.41M | Sell |
101,685
-4,414
| -4% | -$262K | 0.38% | 63 |
|
|
2019
Q2 | $5.78M | Buy |
106,099
+41,526
| +64% | +$2.24M | 0.36% | 68 |
|
|
2019
Q1 | $3.48M | Buy |
64,573
+11,646
| +22% | +$719K | 0.23% | 90 |
|
|
2018
Q4 | $3.47M | Sell |
52,927
-2,517
| -5% | -$188K | 0.23% | 100 |
|
|
2018
Q3 | $4.37M | Sell |
55,444
-13,283
| -19% | -$950K | 0.3% | 83 |
|
|
2018
Q2 | $4.42M | Buy |
68,727
+3,521
| +5% | +$232K | 0.33% | 72 |
|
|
2018
Q1 | $4.06M | Sell |
65,206
-4,403
| -6% | -$316K | 0.31% | 80 |
|
|
2017
Q4 | $5.05M | Sell |
69,609
-8,939
| -11% | -$650K | 0.34% | 63 |
|
|
2017
Q3 | $6.39M | Buy |
78,548
+75,924
| +2,893% | +$6.01M | 0.45% | 40 |
|
|
2017
Q2 | $246K | Sell |
2,624
-71,028
| -96% | -$5.61M | 0.02% | 315 |
|
|
2017
Q1 | $5.78M | Buy |
73,652
+50,845
| +223% | +$4.06M | 0.48% | 33 |
|
|
2016
Q4 | $1.8M | Buy |
+22,807
| New | +$1.85M | 2.48% | 16 |
|
Other funds holding CVS
VCM
VPM
Cerity Partners's CVS Position: Q1 2026 in Review
Cerity Partners reduced its CVS Health (CVS) stake by 1.4% in Q1 2026, selling an estimated $476K and leaving 440,706 shares worth $31.7M. The position accounts for 0.04% of the portfolio, ranked #331.
Cerity Partners first reported a position in CVS in Q4 2016 and has held it in 38 quarters since. The position peaked at $99.8M in Q4 2022. 1,865 funds tracked by Wall St. Rank hold CVS as of Q1 2026.
- Cerity Partners held 440,706 shares of CVS Health worth $31.7M as of Q1 2026.
- Cerity Partners sold 6,181 CVS Health shares in Q1 2026, an estimated $476K.
- CVS Health made up 0.04% of Cerity Partners's portfolio in Q1 2026, its #331 holding.
- Cerity Partners first reported a position in CVS Health in Q4 2016 and has held it in 38 quarters since.
- Cerity Partners's CVS Health position peaked at $99.8M in Q4 2022.
- 1,865 funds tracked by Wall St. Rank held CVS Health as of Q1 2026.
Based on Cerity Partners's 13F filing for Q1 2026, filed 15 May 2026.